Biomanufacturing Featured Articles
-
The 6 Must Haves Of Bioprocess Software
10/11/2023
Utilizing modern technologies to create bioprocess software and discover scalable solutions that meet your existing and future data needs for bioprocessing.
-
Sustainable Freezing In Biopharma
9/11/2023
How does this pivot to natural gas-driven refrigeration platforms in the pharmaceutical manufacturing arena pose challenges and is sustainable cryopreservation possible?
-
Cryopreservation In Stem Cell Therapy
9/5/2023
The cryopreservation process maintains the structural integrity of living cells, but what other information is crucial for manufacturers when considering cryopreservation and its impact on cell-based therapies?
-
What We Can Learn From The Cancer Drug Shortages
8/30/2023
The dramatic shortage of essential cancer drugs, including cisplatin and carboplatin, has exposed gaps in the pharmaceutical supply chain. Here's what we can learn from it about building resilience and how alternatives like monoclonal antibodies can help reduce reliance on cornerstone therapies.
-
Ensure Data Integrity And Traceability Throughout The BioPharma Lifecycle
8/22/2023
A holistic approach to data management may be the only way for BioPharma companies to gain control at every step of the product lifecycle and build the foundation for lasting competitiveness.
-
Lowering The Lipid Barrier To RNA-LNP Therapeutics
8/22/2023
Industry experts discuss current and future trends, formulating successful lipid compositions and navigating the constantly evolving genomic medicine landscape.
-
Fast Track RNA-LNP Drug Development By Lowering The Lipid Barrier
8/21/2023
Fast-track RNA-LNP development, streamline screening with off-the-shelf ionizable lipid mixes, and utilize validation strategies to generate reproducible and scalable LNPs for lead candidates.
-
How Serum Institute Delivered A ‘Breath Of Relief’ In 6 Months
8/16/2023
Kedar Gokhale, an executive director at Serum Institute of India, explains how the world's largest vaccine manufacturer refocused a construction project and achieved commercial scale for the Covovax vaccine in just six months. The feat earned Serum two 2023 ISPE Facility of the Year Awards. This Q&A is part of a feature series on select FOYA winners.
-
Prioritize Particulate Control For Safer Therapy Development
8/10/2023
As particulate control continues to be a top concern for advanced therapy manufacturers, SUT suppliers must regularly assess every element of the single-use component supply chain.
-
Freezing mRNA: Best Practice
7/14/2023
By following some of the best practices in freezing mRNA, you can effectively balance product quality, cost-effectiveness, process safety, and efficiency.